Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma

Citations Over TimeTop 11% of 2015 papers

Abstract

Glioblastomas (GBMs) are deadly tumors of the central nervous system. Most GBM exhibit homozygous deletions of the CDKN2A and CDKN2B tumor suppressors at 9p21.3, although loss of CDKN2A/B alone is insufficient to drive gliomagenesis. MIR31HG, which encodes microRNA-31 (miR-31), is a novel non-coding tumor suppressor positioned adjacent to CDKN2A/B at 9p21.3. We have determined that miR-31 expression is compromised in >72% of all GBM, and for patients, this predicts significantly shortened survival times independent of CDKN2A/B status. We show that miR-31 inhibits NF-κB signaling by targeting TRADD, its upstream activator. Moreover, upon reintroduction, miR-31 significantly reduces tumor burden and lengthens survival times in animal models. As such, our work identifies loss of miR-31 as a novel non-coding tumor-driving event in GBM.

Related Papers

• → CDKN2A/B Alterations Impair Prognosis in Adult BCR-ABL1 –Positive Acute Lymphoblastic Leukemia Patients(2011)73 cited
• → Biallelic loss ofCDKN2Ais associated with poor response to treatment in pediatric acute lymphoblastic leukemia(2016)49 cited
• → Expression Analysis of Genes Involved in the RB/E2F Pathway in Astrocytic Tumors(2015)17 cited
• → Abstract 311: Loss of the tumor suppressor genes CDKN2A/ARF impairs prognosis in adult BCR-ABL1 positive acute lymphoblastic leukemia (ALL)(2011)1 cited
• → 520P Copy number variation spectrum analysis of primary glioblastoma(2023)